Zhe Liang Selected Research

Zhe Liang Research Topics

Disease

27	Sepsis (Septicemia) 03/2024 - 10/2013
7	Inflammation (Inflammations) 03/2024 - 10/2012
6	Pneumonia (Pneumonitis) 01/2023 - 01/2012
6	Neoplasms (Cancer) 01/2022 - 01/2014
4	Infections 01/2024 - 10/2012
2	Bacteremia 01/2023 - 01/2013
2	Atherosclerotic Plaque (Atheroma) 12/2022 - 10/2021
2	Atherosclerosis 12/2022 - 10/2021
2	Obesity 01/2022 - 03/2011
2	Myocardial Infarction 01/2021 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2019 - 05/2015
2	Insulin Resistance 07/2013 - 11/2010
2	Alzheimer Disease (Alzheimer's Disease) 09/2004 - 03/2002
1	Dysbiosis 03/2024
1	Pseudomonas Infections 01/2023
1	Rheumatoid Arthritis 01/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022
1	Calcinosis 10/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Ischemic Stroke 01/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021
1	Heart Failure 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Coronary Disease (Coronary Heart Disease) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Dehydration (Water Stress) 08/2018
1	Fatigue 08/2018
1	Carcinogenesis 01/2018
1	Shock 01/2018
1	Endotoxemia 01/2018
1	Bacterial Infections (Bacterial Infection) 01/2014
1	Adenocarcinoma 01/2014
1	Atrophy 10/2013
1	Morbid Obesity 07/2013
1	Pulmonary Edema 01/2013

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2018 - 01/2012
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2012
3	Phosphotransferases (Kinase)IBA 01/2023 - 10/2013
3	Myosin-Light-Chain KinaseIBA 01/2023 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 09/2004
3	Myosins (Myosin)IBA 01/2023 - 01/2017
3	Tight Junction ProteinsIBA 01/2020 - 01/2016
3	Interleukin-2 (IL2)IBA 01/2016 - 01/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2015 - 09/2004
3	salicylhydroxamic acid (SHAM)IBA 10/2013 - 01/2012
2	Claudin-2IBA 03/2024 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2023 - 12/2020
2	Ethanol (Ethyl Alcohol)IBA 01/2023 - 01/2016
2	Atorvastatin (Lipitor)FDA Link 12/2022 - 10/2021
2	HydrogelsIBA 08/2018 - 08/2018
2	AntigensIBA 11/2016 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 07/2013 - 11/2010
1	Drinking WaterIBA 01/2024
1	Small Interfering RNA (siRNA)IBA 01/2023
1	Pioglitazone (Actos)FDA Link 12/2022
1	Hematoxylin (Haematoxylon)IBA 12/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2022
1	Proteoglycans (Proteoglycan)IBA 01/2022
1	Junctional Adhesion Molecule AIBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	LipidsIBA 10/2021
1	CalciumIBA 10/2021
1	Interleukin-27 (Interleukin 27)IBA 02/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	evolocumabIBA 01/2021
1	alirocumabIBA 01/2021
1	CaspasesIBA 01/2021
1	Chemokine ReceptorsIBA 01/2020
1	Bromodeoxyuridine (BrdU)IBA 01/2019
1	LipopolysaccharidesIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	honokiolIBA 01/2018
1	Caspase 8 (Caspase-8)IBA 01/2018
1	Small Heat-Shock ProteinsIBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 11/2016
1	anti-LFA-1 monoclonal antibody (Odulimomab)IBA 11/2016
1	Claudin-5IBA 01/2016
1	OccludinIBA 01/2016
1	InterferonsIBA 05/2015
1	Annexin A5IBA 05/2015
1	O(4)-methylthymidine triphosphateIBA 01/2014
1	Bacterial AntigensIBA 01/2014
1	ChylomicronsIBA 01/2014
1	NF-kappa B (NF-kB)IBA 10/2013
1	Indicators and Reagents (Reagents)IBA 07/2013
1	Sulfhydryl Compounds (Thiols)IBA 10/2012
1	DisulfidesIBA 10/2012

Therapy/Procedure

17	Ligation 01/2024 - 01/2012
17	Punctures 01/2024 - 01/2012
5	Therapeutics 01/2024 - 01/2020
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 03/2011 - 11/2010
1	Precision Medicine 01/2023
1	Secondary Prevention 01/2021
1	Immunotherapy 01/2021
1	Drug-Eluting Stents 01/2020
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020
1	Percutaneous Coronary Intervention 01/2020
1	Immunomodulation 11/2016